Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Stempoint Capital Lp
Form 13F · Q2 2026

Stempoint Capital Lp

CIK 1952142申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$5.8亿
申报组合市值
85
持仓数量
11
Quarters on record
Top 50
持仓数量

Stempoint Capital Lp——持仓

共 85 个持仓中的前 50 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1TNGX Tango Therapeutics Inc1.2M+508.7%$3823万6.6%
2ABVX Abivax Sa283,657−9.6%$3780万6.5%
3RVMD Revolution Medicines Inc159,943−43.2%$2995万5.2%
4ERAS Erasca Inc1.6M+552.8%$2869万4.9%
5TYRA Tyra Biosciences Inc632,754+227.6%$2021万3.5%
6DNTH Dianthus Therapeutics Inc200,851+134.9%$1958万3.4%
7ELVN Enliven Therapeutics Inc346,914−4.5%$1761万3.0%
8MLYS Mineralys Therapeutics Inc602,686+13.0%$1626万2.8%
9BHVN Biohaven Ltd1.1M−33.3%$1584万2.7%
10SRZN Surrozen Inc602,798+14.7%$1379万2.4%
11KNSA Kiniksa Pharmaceuticals Intl209,234—$1338万2.3%
12SRRK Scholar Rock Hldg Corp239,146−76.9%$1315万2.3%
13ALKS Alkermes Plc248,015+208.1%$1299万2.2%
14TRAX First Tracks Biotherapeutics622,723—$1253万2.2%
15PRAX Praxis Precision Medicines I37,243−33.8%$1247万2.1%
16ROIV Roivant Sciences Ltd348,408−9.7%$1233万2.1%
17BIOA Bioage Labs Inc464,171+37.1%$1138万2.0%
18CGON Cg Oncology Inc159,349−22.5%$1132万2.0%
19ORKA Oruka Therapeutics Inc116,461—$1108万1.9%
20IMVT Immunovant Inc276,527−63.0%$1065万1.8%
21CELC Celcuity Inc98,203+63.5%$1027万1.8%
22RLMD Relmada Therapeutics Inc1.5M+144.4%$1010万1.7%
23CLYM Climb Bio Inc742,745—$969万1.7%
24SYRE Spyre Therapeutics Inc106,926−36.2%$949万1.6%
25ZURA Zura Bio Ltd1.4M+81.6%$807万1.4%
26IFRX Inflarx Nv3.2M—$723万1.2%
27AMLX Amylyx Pharmaceuticals Inc384,304−42.6%$690万1.2%
28CLDX Celldex Therapeutics Inc New178,412−29.8%$664万1.1%
29OVID Ovid Therapeutics Inc2.4M—$650万1.1%
30EQ Equillium Inc2.0M—$645万1.1%
31DFTX Definium Therapeutics Inc137,124−57.9%$645万1.1%
32CYTK Cytokinetics Inc75,603−41.7%$644万1.1%
33DMRA Damora Therapeutics Inc216,194—$562万1.0%
34IVA Inventiva Sa1.4M—$539万0.9%
35IPSC Century Therapeutics Inc2.1M—$526万0.9%
36AURA Aura Biosciences Inc714,280—$507万0.9%
37EYPT Eyepoint Inc338,471−58.3%$484万0.8%
38ASMB Assembly Biosciences Inc170,378−8.1%$468万0.8%
39WHWK Whitehawk Therapeutics Inc1.0M+8.7%$468万0.8%
40XENE Xenon Pharmaceuticals Inc76,075−46.0%$459万0.8%
41QURE Uniqure Nv88,115+12.9%$406万0.7%
42CMPS Compass Pathways Plc284,769—$403万0.7%
43AVLN Avalyn Pharmaceuticals Inc118,000—$388万0.7%
44MPLT Maplight Therapeutics Inc106,906+6.9%$383万0.7%
45ALMS Alumis Inc135,736−40.9%$382万0.7%
46AXSM Axsome Therapeutics Inc.15,375—$376万0.6%
47GLUE Monte Rosa Therapeutics Inc153,544—$372万0.6%
48ACAD Acadia Pharmaceuticals Inc143,167−41.0%$362万0.6%
49SLDB Solid Biosciences Inc358,780+83.6%$358万0.6%
50PSNL Personalis Inc247,783—$332万0.6%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。